Mortality outcomes and survival patterns of patients with myeloproliferative neoplasms in Malaysia-Reference-Cited by-同舟云学术

Mortality outcomes and survival patterns of patients with myeloproliferative neoplasms in Malaysia

Published:2021-11-30 Issue:2 Volume:33 Page:343-351
ISSN:0957-5243
Container-title:Cancer Causes & Control
language:en
Short-container-title:Cancer Causes Control

Author:

Yap Yee Yee^ORCID,Sathar Jameela,Law Kian Boon,Tan Sen Mui,Lau Ngee Siang,Ong Tee Chuan,Goh Ai Sim,Chew Teng Keat,Lim Soo Min,Toh See Guan,Sim Xavier Yoon Han,Menon Padmini,Guan Yong Khee,Husin Azlan Bin,Wong Lily Lee Lee,Chew Lee Ping,Salleh Sinari,Goh Kim Yen,Leong Kin Wah,Lim Su Hong,Edmund Syed Carlo,Tan Jenq Tzong,Gan Gin Gin,Yegappan Subramaniam,Chang Kian Meng,

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10552-021-01521-2.pdf

Reference39 articles.

1. Geyer JT, Orazi A (2016) Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnostic principles and upcoming updates. Int J Lab Hematol 38(S1):12–19. https://doi.org/10.1111/ijlh.12509

2. Campbell PJ, Griesshammer M, Döhner K, Döhner H, Kusec R, Hasselbalch HC et al (2006) V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis. Blood 107(5):2098–2100. https://doi.org/10.1182/blood-2005-08-3395

3. Barosi G, Bergamaschi G, Marchetti M, Vannucchi AM, Guglielmelli P, Antonioli E et al (2007) JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. Blood 110(12):4030–4036. https://doi.org/10.1182/blood-2007-07-099184

4. Tefferi A, Lasho TL, Schwager SM, Steensma DP, Mesa RA, Li C-Y et al (2005) The JAK2V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates. Br J Haematol 131(3):320–328. https://doi.org/10.1111/j.1365-2141.2005.05776.x

5. Cervantes F, Dupriez B, Pereira A, Passamonti F, Reilly JT, Morra E et al (2009) New prognostic scoring system for primary myelofibrosis based on a study of the International working group for myelofibrosis research and treatment. Blood 113(13):2895–2901. https://doi.org/10.1182/blood-2008-07-170449

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives;Frontiers in Oncology;2024-07-24

2. The personal impact of living with a myeloproliferative neoplasm;Psycho-Oncology;2024-04

3. Predictors of survival in the Egyptian patients with primary myelofibrosis: a single-center prospective cohort study;The Egyptian Journal of Haematology;2023-04